Indian F&O data, and the evidence about what not to trade · educational
TORNTPHARM · Healthcare
1M / 3M / 1Y
+0.7% / +8.5% / +36.7%
Traded value (60d med)
₹195 cr
Days in F&O ban since 2020
0
Futures OI / 1d change
2.9M / -0.0M
ATM implied vol
20% (vs 21% realized)
📜 Results-day history
Typical move 1.6% · up on the day 52% of 27 events · moved 4%+ in 30% · worst -6.9% / best +10.1%
| Reaction day | Move | Open gap | Next 5d | Announced |
|---|
| 2026-07-15 | +0.9% | +0.0% | +0.3% | after close |
| 2026-04-27 | +2.5% | +0.2% | +0.8% | during mkt |
| 2026-01-22 | +1.0% | +0.0% | -2.2% | after close |
| 2025-10-16 | +0.0% | +0.1% | +2.3% | after close |
| 2025-07-21 | +0.1% | +0.0% | +2.8% | during mkt |
| 2025-04-30 | -0.0% | +0.0% | -4.1% | after close |
| 2025-01-24 | -0.5% | +0.2% | +0.6% | during mkt |
| 2024-10-28 | -3.4% | +0.1% | -3.5% | after close |
Educational data reference: NOT investment advice. Historical statistics do not predict future results. We are not SEBI-registered advisers. All data from NSE public sources; figures may contain errors. Trading, especially leveraged F&O, can cause significant losses.